Morristown-based Alvogen Inc. announced two lots of a transdermal patch used for delivery of the synthetic opioid Fentanyl have been recalled because the patches inside some cartons may contain a ...

Credit: Alvogen, Inc. Fentanyl is an opioid agonist indicated for the management of severe or persistent pain in opioid-tolerant patients. At this time, Alvogen Inc has received 1 serious adverse ...

Objective: To summarize the pharmaceutics, pharmacokinetics, development, and clinical application of IONSYS, the fentanyl HCl patient-controlled iontophoretic transdermal system for the management of ...

Alvogen, Inc. is voluntarily recalling one lot of Fentanyl Transdermal System 25 mcg/h transdermal patches to the consumer level. The reason for the recall is that there is a potential that patches ...

Transdermal GFR System (TGFR) is a first-in-kind product for point of care assessment of kidney function in patients with normal or impaired renal function The transdermal GFR (tGFR) methodology has ...

MediBeacon ® Transdermal GFR System is a first-in-kind product for point of care kidney function assessment Centers of Excellence ...

VANCOUVER, BC / ACCESSWIRE / June 8, 2020 / XPhyto Therapeutics Corp. (CSE:XPHY / FSE:4XT / OTC:XPHYF) ("XPhyto" or the "Company") is pleased to announce that its wholly owned German subsidiary, ...

Please provide your email address to receive an email when new articles are posted on . Biomind Labs Inc. announced it has received a Controlled Substances License and will begin an 8-month project to ...

Philadelphia, US – Shire plc (LSE: SHP, NASDAQ: SHPGY, TSX: SHQ) announced that its methylphenidate transdermal system (MTS), DAYTRANA TM demonstrated statistically significant reductions in the ...

DUBLIN--(BUSINESS WIRE)--The "Transdermal Drug Delivery System Market - Forecasts from 2022 to 2027" report has been added to ResearchAndMarkets.com's offering. The transdermal drug delivery system ...

FREMONT, Calif., Jan. 05, 2022 (GLOBE NEWSWIRE) -- Zosano Pharma Corporation (NASDAQ:ZSAN), a clinical-stage biopharmaceutical company, today announced the publication of Phase 1 clinical trial data ...

May 28, 2004 -- A buccal testosterone delivery system is superior to the transdermal system, according to the results of a randomized trial published in the May issue of the Journal of Clinical ...